Surg Today 2011,41(1):101–106 PubMedCrossRef 21 Leung KF, Chui A

Surg Today 2011,41(1):101–106.PubMedCrossRef 21. Leung KF, Chui AK, Leung KL, Lai PB, Liew CT, Lau WY: Clinicopathological study of hepatocellular carcinoma with diaphragmatic involvement. Br J Surg 2001,88(5):681–682.PubMedCrossRef 22. Jeng KS, Chen BF, Lin HJ: En bloc resection for extensive hepatocellular carcinoma: is it advisable? World J Surg 1994,18(6):834–839.PubMedCrossRef 23. Wu CC, Ho WL, Liu TJ: Hepatocellular carcinoma Cell Cycle inhibitor with adjacent organ extension: the enhancement of preoperative transcatheter arterial embolization and the results of surgical resection. Surg Today 1994,24(10):882–888.PubMedCrossRef 24. Tung WY, Chau GY, Loong CC,

Wu JC, Tsay SH, King KL, Huang SM, Chiu JH, Wu CW, Lui WY: Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol 1996,22(5):516–520.PubMedCrossRef 25. Kaur R, Abdullah B, Rajasingam V: Hepatocellular carcinoma with extension to the diaphragm, falciform ligament, rectus abdominis and paraumbilical vein. Biomed Imaging Interv J 2008,4(4):e37.PubMedCrossRef 26. Maruyama H, Yoshida

H, Hirakata A, Matsutani T, Yokoyama T, Suzuki S, Matsushita A, Sasajima K, Kikuchi Y, Uchida E: Surgical treatment of a patient with diaphragmatic invasion by a ruptured hepatocellular carcinoma with biliary and portal venous tumor thrombi. J Nihon Med Sch 2012,79(2):147–152.CrossRef Competing interests HDAC inhibitor The authors declare that they have no competing interests. Authors’ contributions MHY coordinated the team, helped in literature research and edited the final version of the manuscript. PKK collected the information and wrote the article SIY researched the literature and wrote the article. All authors read and approved the final manuscript.”
“Background Globally, illegally induced Angiogenesis inhibitor abortion constitutes mafosfamide a major public health problem and in

Africa particularly, the picture is of increasingly hospital admissions for abortion complications and a distressingly high rate of maternal morbidity and mortality due to abortions [1, 2]. Worldwide, there are 30-50 million induced abortions that result in the death of 80,000 – 110,000 women of which an estimated 34,000 are in Sub–Saharan Africa [1, 3]. In settings where access to abortion is highly restricted and desire to regulate fertility is low, deaths due to abortion is a major contributor to maternal mortality [3]. In Tanzania, the law on abortion is highly restrictive and does not permit termination of pregnancy except when it is needed to save the life of a woman [4]. Consequently, women frequently resort to clandestine abortion performed by unskilled practitioners, leading to high rates of maternal mortality and morbidity. The most common reasons for induced abortion are unwanted pregnancy, having lactating small child, health problems, economic and social or family problems that forced women to induce abortion [5–7].

Comments are closed.